![](/images/graphics-bg.png)
Rebamipide, an Amino Acid Analog of 2(1H)-Quinolinone, Inhibits the Formation of Human Osteoclasts
المؤلفون المشاركون
Yamanaka, Hisashi
Nanke, Yuki
Yago, Toru
Kawamoto, Manabu
Kobashigawa, Tsuyoshi
Kotake, Shigeru
المصدر
العدد
المجلد 2016، العدد 2016 (31 ديسمبر/كانون الأول 2016)، ص ص. 1-7، 7ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2016-11-14
دولة النشر
مصر
عدد الصفحات
7
التخصصات الرئيسية
الملخص EN
Objectives.
Drug repositioning or drug reprofiling (DR) has recently been growing in importance.
DR has a significant advantage over traditional drug development because the repositioned drug has already passed toxicity tests; its safety is known, and the risk of adverse toxicology is reduced.
In the current study, we investigated the role of rebamipide, a mucosa-protecting agent, with recently reported anti-inflammatory function, in human osteoclastogenesis.
Methods.
Peripheral blood mononuclear cells (PBMCs) were cultured in the presence of M-CSF and sRANKL.
Osteoclast formation was evaluated by immunohistological staining for CD51/61 (vitronectin receptors).
Osteoclast formation, in the presence or absence of rebamipide (0, 1, and 3 mM), was observed by time-lapse photography and actin ring formation.
The number of absorption sites and area of absorption were calculated using Osteologic™ plates.
Pit formation was studied by 3D-SEM.
Results.
Rebamipide inhibited human osteoclast formation at 3 mM, a pharmacological concentration, and inhibited resorbing activity dose-dependently.
Rebamipide induced the degradation of actin rings in mature osteoclasts.
This mechanism may involve inhibiting the osteoclast fusion pathway through reducing the expression of DC-specific transmembrane protein (DC-STAMP).
Conclusions.
The present study suggests that rebamipide would be useful as a novel agent for osteoporosis and rheumatoid arthritis.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Nanke, Yuki& Kobashigawa, Tsuyoshi& Yago, Toru& Kawamoto, Manabu& Yamanaka, Hisashi& Kotake, Shigeru. 2016. Rebamipide, an Amino Acid Analog of 2(1H)-Quinolinone, Inhibits the Formation of Human Osteoclasts. BioMed Research International،Vol. 2016, no. 2016, pp.1-7.
https://search.emarefa.net/detail/BIM-1098599
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Nanke, Yuki…[et al.]. Rebamipide, an Amino Acid Analog of 2(1H)-Quinolinone, Inhibits the Formation of Human Osteoclasts. BioMed Research International No. 2016 (2016), pp.1-7.
https://search.emarefa.net/detail/BIM-1098599
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Nanke, Yuki& Kobashigawa, Tsuyoshi& Yago, Toru& Kawamoto, Manabu& Yamanaka, Hisashi& Kotake, Shigeru. Rebamipide, an Amino Acid Analog of 2(1H)-Quinolinone, Inhibits the Formation of Human Osteoclasts. BioMed Research International. 2016. Vol. 2016, no. 2016, pp.1-7.
https://search.emarefa.net/detail/BIM-1098599
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1098599
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)